BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23350633)

  • 1. Survival of patients with Stage III colon cancer is improved in hereditary non-polyposis colorectal cancer compared with sporadic cases. A Danish registry based study.
    Brixen LM; Bernstein IT; Bülow S; Ehrnrooth E
    Colorectal Dis; 2013 Jul; 15(7):816-23. PubMed ID: 23350633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members.
    Watson P; Lin KM; Rodriguez-Bigas MA; Smyrk T; Lemon S; Shashidharan M; Franklin B; Karr B; Thorson A; Lynch HT
    Cancer; 1998 Jul; 83(2):259-66. PubMed ID: 9669808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of survival between patients with hereditary non polyposis colorectal cancer (HNPCC) and sporadic colorectal cancer.
    Haghighi MM; Vahedi M; Mohebbi SR; Pourhoseingholi MA; Fatemi SR; Zali MR
    Asian Pac J Cancer Prev; 2009; 10(2):209-12. PubMed ID: 19537885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Registration of hereditary non-polyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 1999 Nov; 161(45):6174-8. PubMed ID: 10603753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register.
    Myrhøj T; Bisgaard ML; Bernstein I; Svendsen LB; Søndergaard JO; Bülow S
    Scand J Gastroenterol; 1997 Jun; 32(6):572-6. PubMed ID: 9200290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.
    de Vos tot Nederveen Cappel WH; Meulenbeld HJ; Kleibeuker JH; Nagengast FM; Menko FH; Griffioen G; Cats A; Morreau H; Gelderblom H; Vasen HF
    Int J Cancer; 2004 Apr; 109(3):468-71. PubMed ID: 14961589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients.
    You JF; Hsieh LL; Changchien CR; Chen JS; Chen JR; Chiang JM; Yeh CY; Hsieh PS; Fan CW; Liu CT; Tang R
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4244-50. PubMed ID: 16857798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer.
    Bertario L; Russo A; Sala P; Eboli M; Radice P; Presciuttini S; Andreola S; Rodriguez-Bigas MA; Pizzetti P; Spinelli P
    Int J Cancer; 1999 Jan; 80(2):183-7. PubMed ID: 9935197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of hereditary non-polyposis colorectal cancer patients compared with sporadic colorectal cancer patients.
    Stigliano V; Assisi D; Cosimelli M; Palmirotta R; Giannarelli D; Mottolese M; Mete LS; Mancini R; Casale V
    J Exp Clin Cancer Res; 2008 Sep; 27(1):39. PubMed ID: 18803843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer.
    Renkonen-Sinisalo L; Aarnio M; Mecklin JP; Järvinen HJ
    Cancer Detect Prev; 2000; 24(2):137-42. PubMed ID: 10917133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of patients with ovarian cancer due to a mismatch repair defect.
    Crijnen TE; Janssen-Heijnen ML; Gelderblom H; Morreau J; Nooij MA; Kenter GG; Vasen HF
    Fam Cancer; 2005; 4(4):301-5. PubMed ID: 16341807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
    Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
    Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival analysis in families affected by hereditary non-polyposis colorectal cancer.
    Percesepe A; Benatti P; Roncucci L; Sassatelli R; Fante R; Ganazzi D; Bellacosa A; Genuardi M; Neri G; Viel A; Ponz de Leon M
    Int J Cancer; 1997 May; 71(3):373-6. PubMed ID: 9139871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characteristics of hereditary non-polyposis colorectal cancer by the Amsterdam criteria: an Asian perspective.
    Chew MH; Koh PK; Ng KH; Lim JF; Ho KS; Ooi BS; Tang CL; Eu KW
    ANZ J Surg; 2008 Jul; 78(7):556-60. PubMed ID: 18593409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of recognition of the hereditary non-polyposis colon cancer syndrome (HNPCC) for the early detection of colorectal cancer.
    Jablonská M; Rezníková L; Kotrlík J; Svitavský M; Miková M; Tabach J
    Sb Lek; 1995; 96(3):275-82. PubMed ID: 8718819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
    Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
    World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations in patients with hereditary nonpolyposis colorectal cancer.
    Tomoda H; Baba H; Oshiro T
    J Surg Oncol; 1996 Apr; 61(4):262-6. PubMed ID: 8627995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival from colorectal carcinoma in HNPCC families as compared to the general population in Lithuania--initial results.
    Elsakov P; Kurtinaitis J
    Fam Cancer; 2006; 5(4):369-71. PubMed ID: 16826317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.